drugset / Trial / NCT00235482
Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of an injection of coxsackievirus A21 into a melanoma tumour, and also to see if there is a tumour response.
Timeline
- Start
- 2005-11-08
- Primary completion
- 2006-04-21
- Completion
- 2006-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gebasaxturev | Other / unclassified | — | Other |